John Carlos Diaz
President and Owner of GeoSera
John Carlos Diaz is the President and Owner of GeoSera. Prior to starting GeoSera, John Carlos worked in Clinical Research for ten years as a Clinical Operations Leader tasked with delivering endpoints within timelines and budget. John Carlos has held various Clinical Operations roles with increasing levels of responsibility in Clinical Pharmacology at Merck, managing phase I – IV, global, adult/pediatric clinical trials at Cephalon/Teva, and as a Clinical Operations Leader at Braeburn Pharmaceuticals. John Carlos was a Sr. Scientist at GSK within Drug Metabolism and Pharmacokinetics prior to his roles in Clinical Operations.
John Carlos graduated from New York University with a Bachelors Degree in Biochemistry. His scientific background was further complimented by completing a Master’s Degree and professional certificates. John Carlos has a Master’s Degree in Clinical Research from George Washington University and professional certificates in Finance and Accounting from The Wharton School at University of Pennsylvania and Clinical Research from Villanova University.